The cell quality testing platform built by Celconta Group passed the
CNAS recognition, its equipment
and facilities, testing ability and
management ability reached the international level, and the data provided by the
testing platform have legal effect, inspection report recognized by
international peers, issued by the inspection report will be more than 100
countries and regions of the test results of mutual recognition.
Celconta Group has invested
heavily to build the cell quality testing platform. In addition to meeting the
quality control of the group's own stem cell and immune cell
preparations and the quality testing of new product research and development,
the platform can also serve as a third-party testing platform to serve
enterprises, scientific research institutions and medical institutions in the
development, research and application of cell drugs. The platform is currently one of the
most comprehensive testing institutions in China for cell product testing projects, with
the most professional testing methods. The platform can complete the testing of the following ten projects:
